chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Increasing and persistent itching at site of previous case of shingles (ca. 5 years ago). Increased to burning sensation by evening of 3/18. No rash. Burning ceased on 3/19, but itching has continued.  Onset of mild flu-like symptoms on 3/19: achiness, flushed, fatigue; worst on 3/21.  Called doctor on 3/21 am; told it was likely a reaction to shingles vaccine. On 3/22 am, symptoms are less, but not gone.
Facial skin flushing and itching. flushing Sense of swollen glands in neck. RX: oral fluids and benadryl 25mg PO. Improvement in symptom  No shortness of breath,  No swelling Pepcid 40mg was declined by patient.
10/5 :Fri 2:00 PM Nausea,9:30 PM Fell down and could not get up without assistance,  unable to walk or setup, Dizzy and confused, bad itchy rash on body including large red spots(stomach, back, legs, arms, head , neck) Sat 10/6 admitted at Hospital tests results dehydration. Continued problem with walking. Tues 10/9 visit with primary doctor. Pictures were taken of his body and entered in computer at Clinic. Walking issues getting better.
Developed red, hard area left deltoid region. Some itching. Advised ice, Advil, Cortaid, Benadryl prn.
body aches; little sore at injection site; swollen at injection site; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 26-Feb-2021 and was forwarded to Moderna on 26-Feb-2021.    This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE PAIN (little sore at injection site), VACCINATION SITE SWELLING (swollen at injection site) and MYALGIA (body aches) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Jan-2021, the patient experienced VACCINATION SITE PAIN (little sore at injection site) and VACCINATION SITE SWELLING (swollen at injection site). On 24-Feb-2021, the patient experienced MYALGIA (body aches). On 25-Feb-2021, MYALGIA (body aches) had resolved. At the time of the report, VACCINATION SITE PAIN (little sore at injection site) and VACCINATION SITE SWELLING (swollen at injection site) outcome was unknown.            No concomitant medication were reported No treatment medication were reported. The patient received both scheduled doses of mRNA-1273 prior to the event, therefore action taken with the drug in the event is not applicable   This case was linked to MOD-2021-028562, MOD-2021-028562 (Patient Link).
The day of the last vaccine only pain in the arm but after a few weeks I began to feel exhaustion, muscle and joint pain. These pains have increased as the days went by, pain in the chest, dilated veins began to appear at the height of the ribs and in various areas of the body, very frequent headache and liquid stools.
Information has been received from a physician concerning a 5 year old who, on an unknown date between July 2006 to 05-MAR-2007 was vaccinated with the second dose of varicella virus vaccine live (Oka/Merck) (Lot Number 657404/0592U). Subsequently, within two to three days post vaccination, the patient developed a large, two to three inch injection site reaction on the upper arm. The reaction lasted approximately one week. Unspecified medical attention was sought; no treatment was required. The outcome was reported as recovered. No additional information to report. There was no product quality complaint involved. This is one of several reports received from the same source. Additional information has been requested.
Patient complains of severe soreness in left arm after receiving Pneumovax in left deltoid. Also had fever to 102.5 and chills for 24 hours.
pt recv vax 17SEP96 & on 8OCT96 pt returned to center w/varicella;
Pt developed shortness of breath and tightness of throat about 7 hours after admin of vaccine. Pt went immediately to ER, was given IM epinephrine, IV steroids, benadryl and pepcid. Pt observed for about 3 hours and sent home. Pt seen for follow up in primary care office on 5/31/19 for persistent sensation of throat tightness and difficulty swallowing. Was given prednisolone 30mg BID for 3 days.
itching a lot; kinda hard around it; The area still feels different compared to the surrounding skin; red; a little bit raised; This spontaneous case was reported by a consumer and describes the occurrence of   in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included AMOXICILLIN TRIHYDRATE, CLARITHROMYCIN, ESOMEPRAZOLE MAGNESIUM (NEXIUM 1-2-3) for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided
Presented in ER s/d seizure and fever 2/11/03 morning. Immunization 2/10/03, Tylenol in evening.
High fever and chills beginning evening of injections and lasting three days; swollen red upper arm at site of pneumonia injection from day of injection to present time; Motrin, liquids and bed rest as treatment.
Pt recvd 3 doses of Engerix-B & titer result was neg; recvd a 4th dose of Engerix-B & titer was then pos;
Patient developed a "full-bodied rash" 3 days following flu shot that lasted about 2 weeks. Treated with benadryl and steroid cream. Patient did not develop any throat swelling, chest pain, or fever.
Patient observed vaginal bleeding starting today, November 27, 2021, while they are on birth control pills. In the three plus years patient has been on birth control pills they have never experienced break-through bleeding. Patient was on their period when they were vaccinated; patient is now on week two of current birth control pack. Prior to starting birth control pills, patient never experienced break-through bleeding either.
gout flare up; loss of appetite; fatigue; chills; slight temperature; This spontaneous case was reported by a consumer and describes the occurrence of GOUT (gout flare up), DECREASED APPETITE (loss of appetite), FATIGUE (fatigue), CHILLS (chills) and PYREXIA (slight temperature) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039F21A, 010M20A and 003A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 31-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 31-Oct-2021, the patient experienced GOUT (gout flare up), DECREASED APPETITE (loss of appetite), FATIGUE (fatigue), CHILLS (chills) and PYREXIA (slight temperature). At the time of the report, GOUT (gout flare up) had not resolved and DECREASED APPETITE (loss of appetite), FATIGUE (fatigue), CHILLS (chills) and PYREXIA (slight temperature) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were reported. No treatment information was provided by the reporter.   This case was linked to MOD-2021-375387, MOD-2021-375399 (Patient Link).
sense of taste distorted; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 43 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 14Mar2021 10:30 (Batch/Lot number: unknown) at the age of 43 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (yesterday 21FEB2021 at 09:30AM in the left arm), administration date: 21Feb2021, when the patient was 43 years old, for Covid-19 Immunisation. The following information was reported: TASTE DISORDER (non-serious) with onset 15Mar2021, outcome "unknown", described as "sense of taste distorted". Additional information: Reporter who was mother of patient stated that her daughter who was got the shot and felt fine, but her sense of taste was distorted. She was asked that a side effect of the vaccine. There was not any history of all previous immunization with the Pfizer vaccine. No additional vaccines were administered on same date of the Pfizer suspect. There was no family history. Adverse event did not require a visit to physician or ER. No prior vaccinations (within 4 weeks) were administered. None relevant test were performed.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
FEVER X2 DAYS AND REDNESS AND SWELLING X2 DAYS.
This spontaneous report was received from a office manager refers to two patients of unknown age. The medical history, concurrent conditions and concomitant medications were not reported. On 02-OCT-2016, the patients were vaccinated with an improperly stored dose of GARDASIL 9 lot # M007764, 30-JAN-2018. No adverse effect was reported. Temperature was 74.3F for 28 hours and it was administered. There was no previous temperature excursion. This is one of the three cases received from the same reporter. Additional information has been requested.
Patient received Pneumovax and flu shot on 8/3/17. She went home and had complaints of nausea, fever, vomiting, upper back pain, headache, redness in arm, shortness of breath later on and was rushed to the hospital. While at the hospital it was discovered she had a urinary tract infection for which she was treated for. She came back to the pharmacy was angry and complained hospital said she should not have gotten pneumonia vaccine because she is too young. I assured her because she is a diabetic, she is at risk and needs one. She also showed me her arm which was red all over. I told the patient some of her symptoms could have been attributed by her urinary infection and the redness in her arm is a side effect and should go away within a few days.
Patient was seen on 06/22/2001 for a diaper rash. The patient had a fever. During the examination the patient had a seizure that lasted approximately 2 minutes. The fever was 103.1R. After the seizure the patient cried and then slept.
On the day after my second vaccine on 1/28, I had muscle type throbbing in my right thigh.  It stopped after 24 hours.  Around 4/17 I had similar  pain return but it was much more painful.  The pain snd throbbing traveled from my upper thigh to my knee.   It was mostly at night and I could not sleep at all.
pt recvd vax;MTR called & stated pt w/ MGM during day while she took older sib to LR to MD; MGM states pt became limp & collapsed; eyes rolled back; was unresponsive several seconds;no jerking;MGM has sz & told MTR pt episode was like hers;
Emesis noted morning after administration. Patient irritable all day according to parents.  About 24 hours after administration, patient overslept nap. Patient woken up by parents, and noted to have significant erythema and edema on left thigh. Patient given 2.5 ml of benadryl at 1630. Erythema became more intense, patient brought to ER on 11/11/2020 @1800, erythema noted to be 8.5 cm x 6cm located on left thigh. Patient discharged without further intervention, instructed to follow up in clinic. Benadryl 2.5 ml given again at 0800 11/12/2020. Patient seen for f/u appointment on 11/12/2020 at 0900. Slight bruising at point of injection on left thigh. Maximum dimension of erythema is 12cm x 9cm. Warm and firm to touch. No fever. Patient alert, walking around,  good spirits. Patient would sometimes grab at injection site and say "boo boo." No other symptoms or difficulty breathing.
Bruised painful feeling around injection site; Bruised painful feeling around injection site; Achy joints in bilateral elbows and knees; Low fever or flushed feeling.; Low fever or flushed feeling.; This is a spontaneous report from a contactable consumer (patient). A 30-year-old male patient BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in left arm on 25Feb2021 at 19:00 (Lot Number: EN6202, unknown expiration; at the age of 30 years old) as dose 1, single for COVID-19 immunisation. Medical history and concomitant medications reported as none. No known allergies. No other vaccine in four weeks. On 26Feb2021 at 03:00 am, the patient experienced bruised painful feeling around injection site, achy joints in bilateral elbows and knees, and low fever or flushed feeling. The patient did not receive treatment for the events. No COVID prior to vaccination and has not been tested for COVID post vaccination. The patient recovered from the events in Feb2021.   No follow up attempts are possible. No further information is expected.
Patient received routine vaccines listed above. Patient complained of feeling weak. Patient assessed by RN. Patient vitals checked. P- 88, O2 SAT- 98%, BP- 110/72 R-20. Patient assisted to the floor. Patient legs elevated. Patient states feeling better.  Patient assisted back to chair. Offered to call EMS for patient.  Patient and family member refused. Patient monitored for 30 minutes. Follow up post vaccination instructions from system drink, monitor self, report any lingering physical complaints to own provider. Instruction given regarding calling 911 or going to local emergency room for emergency symptoms. Translation provided. Patient and family verbalized understanding.
Headache, fever (101 degree) ,  violent shaking, and exhaustion; lasted about 36 hours.
intermittent pain; redness; Purple spot under the nail of her second toe on her left foot; walks with a limp; This case was reported by a consumer via call center representative and described the occurrence of pain in a 81-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of injection site pain (received 1st dose on 16th May 2018, refer case US2019GSK078466).   On 12th September 2018, the patient received the 2nd dose of Shingrix. On 14th September 2018, 2 days after receiving Shingrix, the patient experienced pain, erythema, skin discoloration and limping. On an unknown date, the outcome of the pain was recovered/resolved and the outcome of the erythema and limping were unknown and the outcome of the skin discoloration was not recovered/not resolved.   It was unknown if the reporter considered the pain, erythema, skin discoloration and limping to be related to Shingrix.  Additional details were provided as follows: Two days after receiving Shingrix vaccine she developed a purple spot under the nail of her second toe on her left foot. Also, the skin around the nail and at the tip of the toe was red. She has intermittent pain that she reports was at in 8 on a scale from 1 to 10. An X ray was taken and blood was taken to test for gout. Everything came back negative. She has had other tests performed since them, all negative results. She indicated that the pain occurs when she was standing only. She does describe that the redness and purple spot have faded but she still has this intermittent pain.  The physician reported that the patient walks with a limp when she was experiencing the pain.  The reporter consented to follow up. The reporter gave permission for her physician to be contacted. The reporter was unable to provide any additional information.      Lab Comments: Everything came back negative. She has had other tests performed since them, all negative results.
Extremely Tired, Head Heavy, felt off  like body felt  like weak muscles felt jellowy
It was reported that a female patient received a Typhim Vi vaccination on 11/15/99. Reportedly on 11/19/99, the patient developed swelling of the left parotid gland and a low grade fever.
Light-headed, fuzzy 0HA, 0vision changes, 0 chest pressure, 0 SOB 0 wheezing 0 urticaria.
soreness; This is a spontaneous report from a non-contactable physician via Pfizer sales representative. A patient of unspecified age and gender received bnt162b2 (BNT162B2 also reported as Pfizer COVID-19 vaccine, lot/batch number and expiry date were not reported), via an unspecified route of administration on an unspecified date at single dose for Covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient reported very mild soreness with first and second dose of Pfizer COVID-19 vaccine. The outcome of event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained
Fever; Got sick; I am exhausted all time; Feels like I got flu; This is a spontaneous report received from a contactable consumer (patient). A 52-year-old female (patient) received first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number and expiry date were not reported), via an unspecified route of administration, in Arm Left, on 10Apr2021 (age at vaccination: 52 years), as dose 1, single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient reported that she took her first shot on 10Apr2021 and then a week later that was on Sunday, on 17Apr2021, she got sick, and she was still sick a whole week later. She didn't know like what's going on and what should she do. On an unspecified date in Apr2021, she was exhausted all the time. She means she always got a fever on 18Apr2021. It's felt like she got a flu every day and asked should she go to the doctor. The patient's second shot vaccination due date was 01May2021. The patient took Aspirin, Ibuprofen and cold or Flu medicine as treatment. Outcome of the events was not recovered.  No follow-up attempts are needed. No further information is expected.
Shingles shots years ago, broke out between the two shots; This case was reported by a consumer via interactive digital media  and described the occurrence of shingles in a 62-year-old patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (the patient experienced first shingles at the age of 20 years, and patient had them twice a year).   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.  Additional details were provided as follows: The age at vaccination was not reported. The patient got the shingles shots years ago and was told would not ever need vaccine again but did broke out between the 2 shots. The patient had shingles off and on for years. The follow-up would not possible as no contact details were available. For tolerance of 2nd dose refer case US2021AMR183413 and US2021AMR188646. This is 1 of 4 linked cases reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR188646:Same reporter. US-GLAXOSMITHKLINE-US2021AMR183413:Same reporter US-GLAXOSMITHKLINE-US2021AMR188679:Same reporter
Symptoms: Fever, chills, nausea, body aches, headache Treatment: Tylenol, rest, fluids
Swelling, pain in arm, joint pain, chills, slight fever, congestion, headache.
Development of seriously swollen lymph nodes under both arms and across the base of the neck - acute swelling and pain, slight fever, pain under left rib, fast heart rate for days, slight pleural infusion in left lung. Swollen lymph nodes lasted for 6days despite use of acetaminophen and ibuprofen. Rapid heart rate continues to persist 7 days after injection. Pain beneath rib became acute - saw doctor today - chest x-ray reveals slight pleural infusion in lower left lung.
On November 13, 2022, we woke up and I felt like I had a cold.  I had a really sore throat that felt like a pin-point stabbing pain, but it only lasted overnight.  The next day I just had some nasal congestion.  I was prescribed Paxlovid and began taking it on November 18th.  After I began taking the prescription, I still had the same cold symptoms.
Pt recv vax on 10/16/98; 1 hr later pt exp high pitched screaming for 4 hr; pt slept 15 min at a time.
AFIB; fainting; POTS; constantly tearing eyes; abdominal pain; brain fog; This spontaneous case was reported by a patient and describes the occurrence of ATRIAL FIBRILLATION (AFIB) and SYNCOPE (fainting) in a male patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced ATRIAL FIBRILLATION (AFIB) (seriousness criterion medically significant), SYNCOPE (fainting) (seriousness criterion medically significant), POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME (POTS), LACRIMATION INCREASED (constantly tearing eyes), ABDOMINAL PAIN (abdominal pain) and FEELING ABNORMAL (brain fog). At the time of the report, ATRIAL FIBRILLATION (AFIB), SYNCOPE (fainting), POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME (POTS), LACRIMATION INCREASED (constantly tearing eyes), ABDOMINAL PAIN (abdominal pain) and FEELING ABNORMAL (brain fog) had not resolved.            No concomitant medications were reported. The patient experienced unspecified more events and whatever the issues he was facing after the vaccine were not going away. Patient reported that he would never take a vaccine again. No treatment medications were reported.  Company comment: This spontaneous case concerns a male patient of unknown age, with no reported medical history, who experienced the unexpected serious (medically significant) events of Atrial fibrillation (also AESI), Syncope; unexpected non serious AESI of Postural orthostatic tachycardia syndrome, unknown time after receiving a dose of mRNA-1273.222 bivalent vaccine. The patient also experienced constant tearing, abdominal pain and brain fog along with the events. No information on risk factors, detailed clinical course, relevant investigations, treatment of the events was available in the report. The events had not resolved. The benefit-risk relationship of mRNA-1273.222 bivalent vaccine is not affected by this report.   This case was linked to US-MODERNATX, INC.-MOD-2023-720715, US-MODERNATX, INC.-MOD-2023-720716 (Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 25-Apr-2023: Live Non significant follow up received.; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-720715:14 year old US-MODERNATX, INC.-MOD-2023-720716:15 year old
Tingling toes sensation. "It feels like my toes are moving, but they're not moving" Persisted for about 4-5 minutes. Sensation returned the following day around 11:30 and lasted about an hour "before lunch, during lunch, and a little after lunch"  Also, as with other vaccine injections, experienced small little blistering bumps around the injection site. Causes itching. Disappears over the course of ~10 days.
Client fainted. Out approx 30 seconds. Applied cool compress to back of neck. Had patient place head between knees for several minutes. Observed for 15 minutes.